LSV Asset Management Invests $145,000 in Ultralife Co. (NASDAQ:ULBI)

LSV Asset Management bought a new stake in Ultralife Co. (NASDAQ:ULBI) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 19,400 shares of the technology company’s stock, valued at approximately $145,000. LSV Asset Management owned 0.12% of Ultralife at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ULBI. IFP Advisors Inc purchased a new position in shares of Ultralife in the 4th quarter valued at about $85,000. Barclays PLC raised its holdings in Ultralife by 21.3% in the third quarter. Barclays PLC now owns 13,395 shares of the technology company’s stock valued at $121,000 after acquiring an additional 2,355 shares in the last quarter. Jane Street Group LLC purchased a new position in Ultralife in the third quarter worth approximately $166,000. Perritt Capital Management Inc grew its holdings in Ultralife by 100.0% during the 4th quarter. Perritt Capital Management Inc now owns 30,000 shares of the technology company’s stock worth $224,000 after acquiring an additional 15,000 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in shares of Ultralife by 35.7% in the 4th quarter. Bank of New York Mellon Corp now owns 43,541 shares of the technology company’s stock valued at $324,000 after purchasing an additional 11,448 shares during the last quarter. 30.68% of the stock is owned by institutional investors and hedge funds.

Ultralife Price Performance

Shares of NASDAQ ULBI opened at $4.41 on Wednesday. The stock’s 50-day simple moving average is $5.81 and its 200-day simple moving average is $7.28. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.62 and a current ratio of 3.30. The firm has a market capitalization of $73.35 million, a PE ratio of 8.02 and a beta of 0.96. Ultralife Co. has a fifty-two week low of $4.20 and a fifty-two week high of $13.39.

Ultralife (NASDAQ:ULBI) last issued its quarterly earnings data on Tuesday, April 1st. The technology company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.14). The company had revenue of $43.85 million for the quarter, compared to analysts’ expectations of $40.00 million. Ultralife had a return on equity of 7.92% and a net margin of 5.44%. During the same quarter in the prior year, the firm posted $0.18 EPS.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Ultralife from a “buy” rating to a “hold” rating in a research note on Tuesday, March 18th.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.